BRAINP
Brain+ ApS
Save
10.83M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Healthcare Information Services
Industry
Brain+ A/S develops digital therapeutics for Alzheimer's and dementia. The company develops cognitive stimulation therapy (CST), a therapy that treats the main symptoms of dementia; Computerized Cognitive Training, a cognitive training method for patients with mild cognitive impairment; and Starry Night, memory test for early detection and monitoring of Alzheimer's. In addition, it develops an interface for clinicians to track and trace the patient's treatment progress.
Similar securities
Based on sector and market capitalization
Report issue